Abstract
A portion of pediatric patients are drug resistant to conventional drug treatment for epilepsy. The ketogenic diet (KD) has been proposed as an adjuvant to the pharmacological treatment prescribed for children and adolescents with drug-resistant epilepsy. Evidence suggests that the high consumption of PUFAs, especially omega 3, optimizes the anti-seizure effects of KD, promoting an improv…